CIPAC Information Sheet no. 344

Coronatine

Please note that the trial is limited to the maximum 15 participating laboratories because of the availability of samples. The selection is based on “first come, first served".

Information Sheets

CIPAC Information Sheet no. 340

Solvents in chlorantraniliprole formulations

Please note that the trial is limited to the maximum 15 participating laboratories because of the availability of samples. The selection is based on “first come, first served".

Information Sheets

CIPAC Information Sheet no. 343

Tembotrione

Please note that the trial is limited to the maximum 15 participating laboratories because of the availability of samples. The selection is based on “first come, first served".

Information Sheets

CIPAC Information Sheet no. 341

494 tebuconazole

Please note that the trial is limited to the maximum 15 participating laboratories because of the availability of samples. The selection is based on “first come, first served".

Information Sheets

Draft CIPAC Guidelines and table for comments 

The document is intended to be a "living document" and existing guidelines shall be replaced step-by-step. 
This is the reason why not all sections of the document are filled. 
Following amendments can be then adopted at CIPAC meetings.

CIPAC would kindly ask you to make your comments, remarks by the end of 2023 in the attached “table for comments” and send it to our secretary Laszlo Bura.

New CIPAC guidelines

Comments to the new guidelines

Upload of the last CIPAC code numbers

1023 14-hydroxylated brassinosteroid
1024 matrine

You will find all numbers in Code numbers and the latest Excel file.